ATE97812T1 - Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen. - Google Patents

Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.

Info

Publication number
ATE97812T1
ATE97812T1 AT89113160T AT89113160T ATE97812T1 AT E97812 T1 ATE97812 T1 AT E97812T1 AT 89113160 T AT89113160 T AT 89113160T AT 89113160 T AT89113160 T AT 89113160T AT E97812 T1 ATE97812 T1 AT E97812T1
Authority
AT
Austria
Prior art keywords
derivative
monosialogangliosids
isopropylester
diseases
nervous system
Prior art date
Application number
AT89113160T
Other languages
English (en)
Inventor
Valle Francesco Della
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Application granted granted Critical
Publication of ATE97812T1 publication Critical patent/ATE97812T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89113160T 1988-07-19 1989-07-18 Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen. ATE97812T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8848208A IT1224513B (it) 1988-07-19 1988-07-19 Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria
EP89113160A EP0351784B1 (de) 1988-07-19 1989-07-18 Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen

Publications (1)

Publication Number Publication Date
ATE97812T1 true ATE97812T1 (de) 1993-12-15

Family

ID=11265246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89113160T ATE97812T1 (de) 1988-07-19 1989-07-18 Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.

Country Status (10)

Country Link
EP (1) EP0351784B1 (de)
JP (1) JPH0278622A (de)
AT (1) ATE97812T1 (de)
AU (1) AU624164B2 (de)
DE (1) DE68911049T2 (de)
DK (1) DK354589A (de)
ES (1) ES2061821T3 (de)
IT (1) IT1224513B (de)
PH (1) PH26117A (de)
ZA (1) ZA895367B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
US6998392B2 (en) * 2003-04-02 2006-02-14 Mti Meta Tech Inc. Formulation to treat or prevent parasitic infection
US8536140B2 (en) 2004-03-12 2013-09-17 Mti Meta Tech Inc. Methods for treating inflammatory bowel disease
US7851451B2 (en) 2004-03-12 2010-12-14 Mti Meta Tech Inc. Formulations for mediating inflammatory bowel disorders
CN104490837A (zh) * 2014-12-30 2015-04-08 哈尔滨医科大学科技开发总公司 单唾液酸四己糖神经节苷脂钠的口服制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi

Also Published As

Publication number Publication date
AU624164B2 (en) 1992-06-04
DK354589A (da) 1990-01-20
DK354589D0 (da) 1989-07-18
PH26117A (en) 1992-02-24
JPH0278622A (ja) 1990-03-19
DE68911049T2 (de) 1994-06-01
EP0351784A3 (en) 1990-12-27
EP0351784B1 (de) 1993-12-01
EP0351784A2 (de) 1990-01-24
DE68911049D1 (de) 1994-01-13
IT8848208A0 (it) 1988-07-19
IT1224513B (it) 1990-10-04
ZA895367B (en) 1990-04-25
AU3819089A (en) 1990-01-25
ES2061821T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
PT716600E (pt) Composicoes para administracao topica contendo derivados do acido 3-benzoilfenilacetico para o tratamento de doencas inflamatorias oftalmicas
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
FI950909A0 (fi) Rasvahappojohdannaisia
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
ATE89556T1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
NO20002649D0 (no) Anvendelse av en blanding av diol og en alfa-hydroksysyre for behandling av hyperkeratotiske hudsykdommer
ATE97812T1 (de) Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.
EP0352826A3 (de) Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten
IT9021768A0 (it) Derivato della melatonina ad attivita' terapeutica in dermatologia
DE59009378D1 (de) Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
IT1189308B (it) L'impiego in terapeutica d'un derivato dell'acetammide
NO974551D0 (no) Bruk av sulbutiamin for å fremskaffe farmasöytiske sammensetninger nyttige i behandling av visse psykomotoriske- og psyko-intellektuelle sykdommer
DK576687D0 (da) Terapeutisk aktive alkensyrederivater
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
LV10952A (lv) Terapeitiski aktivi fluoraizvietoti benzimidazoli to iegusanas panemieni mineto terapeitiski aktivo fluoraizvietoto benzimidazolu pielietojums
IT8629527V0 (it) Cuffia predisposta per fungere da supporto alle cannule per l'irriga zione auricolare nella prova calori ca dell'esame vestibolare
IT8667614A0 (it) Impiego della elastase nel trattamento terapeutico di disturbi della irrorazione sanguigna periferica
IT8448370A0 (it) Citrato trisodico utilizzabile nella cura delle malattie artriticoreumatiche
IT8309569A0 (it) Applicazione terapeutica di farmaci ad attivita' antiproteolitica speci ficanel trattamento delle ulcere torpide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee